Literature DB >> 1686994

Post biliopancreatic bypass arthritis. Dermatitis syndrome.

F P Cantatore1, M Carrozzo, M C Loperfido.   

Abstract

A case of arthritis dermatitis syndrome observed after a biliopancreatic bypass for morbid obesity is described. The syndrome had begun 10 days after surgery and involved the knees, ankles, elbows and wrists and erythema nodosum on the legs. After 15 days treatment with sulfasalazine and steroid the symptoms disappeared. The immunologic aetiology of the disease was postulated and the observation of the syndrome, for the first time, after a biliopancreatic bypass suggested that the manifestation of the disease is independent of the kind of the surgical procedures used for the treatment of the morbid obesity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1686994     DOI: 10.1007/bf02206671

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  18 in total

1.  METABOLIC OBSERVATIONS IN PATIENTS WITH JEJUNOCOLIC SHUNTS.

Authors:  J H PAYNE; L T DEWIND; R R COMMONS
Journal:  Am J Surg       Date:  1963-08       Impact factor: 2.565

2.  Surgical treatment of morbid obesity. Sixteen years of experience.

Authors:  J H Payne; L DeWind; C E Schwab; W H Kern
Journal:  Arch Surg       Date:  1973-04

3.  Rheumatoid arthritis associated with jejunoileal bypass.

Authors:  E J Drenick; L W Bassett; T M Stanley
Journal:  Arthritis Rheum       Date:  1984-11

4.  Overview: jejunoileal bypass in the treatment of morbid obesity.

Authors:  J P O'Leary
Journal:  Am J Clin Nutr       Date:  1980-02       Impact factor: 7.045

5.  Intestinal bypass surgery for morbid obesity. Long-term results.

Authors:  L T DeWind; J H Payne
Journal:  JAMA       Date:  1976-11-15       Impact factor: 56.272

Review 6.  Jejunoileal bypass for morbid obesity. A critical appraisal.

Authors:  J D Halverson; L Wise; M F Wazna; W F Ballinger
Journal:  Am J Med       Date:  1978-03       Impact factor: 4.965

7.  Circulating immune complexes containing secretory IgA in jejunoileal bypass disease.

Authors:  D O Clegg; J J Zone; C O Samuelson; J R Ward
Journal:  Ann Rheum Dis       Date:  1985-04       Impact factor: 19.103

8.  Unusual fungal infections following jejunoileal bypass surgery.

Authors:  A W Tustin; A B Kaiser; R W Bradsher; J L Herrington
Journal:  Arch Intern Med       Date:  1980-05

9.  The intestinal bypass: arthritis-dermatitis syndrome.

Authors:  H B Stein; O L Schlappner; W Boyko; R H Gourlay; C E Reeve
Journal:  Arthritis Rheum       Date:  1981-05

10.  Jejunoileal bypass as a treatment of morbid obesity.

Authors:  J M Campbell; T K Hunt; J H Karam; P H Forsham
Journal:  Arch Intern Med       Date:  1977-05
View more
  1 in total

Review 1.  Biliopancreatic diversion in the surgical treatment of morbid obesity.

Authors:  Robrecht H G G Van Hee
Journal:  World J Surg       Date:  2004-04-19       Impact factor: 3.352

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.